Author's posts
The pharmaceutical industry urges courts to preserve access to abortion pill
As the debate over mifepristone makes its way to the Supreme Court, the pharmaceutical industry has raised concerns that ruling against the FDA could chill the development of new drugs.
The mifepristone ruling may deter the development of new drugs, experts say
The mifepristone ruling in Texas has been met with concern from the pharmaceutical industry, who say the decision, if upheld, could having a chilling effect on the development of new drugs.
The CDC now recommends Pfizer boosters after 5 months, not 6
The move to shorten the Pfizer booster interval comes as the U.S. shatters daily case records. The recommended interval for those who received Moderna or Johnson & Johnson vaccines has not changed.
Missouri Will Not Expand Medicaid Despite Voters’ Wishes, Governor Says
Last year, Missouri voters approved a ballot measure to expand Medicaid. But Republican lawmakers refused to appropriate money to fund it. Now, a legal battle is all but certain.
Rachel Levine Questions State Bills Targeting Transgender Health Care
“I think people fear what they don’t understand,” says Dr. Rachel Levine, assistant secretary for health and the first openly transgender person to serve in a Senate-confirmed position.
Dr. Rachel Levine: Transgender Health Care Is An Equity Issue, Not A Political One
“I think people fear what they don’t understand,” says Levine, assistant secretary for health and the first openly transgender person to serve in a Senate-confirmed position.
